DTM DT Midstream, Inc. Insider Trading

DTM CFO Jewell buys 150 shares at $147.73 ($22.2K), near 52-week high of $150.45, with 5-of-5 prior DTM buys yielding positive 90d returns.

Jewell Jeffrey A, Executive V.P. and CFO of DT Midstream, Inc., purchased 150 shares at $147.73 on 2026-05-15 for a total value of $22,159.50, bringing his post-transaction holdings to 89,732 shares. The purchase occurred with DTM's current price at $148.08, just -1.6% from its 52-week high of $150.45, and following a 30-day gain of +12.3% and a 90-day gain of +11.2%. His 5 prior open-market buys at DTM are notable: each of the 5 generated a positive 90-day return, ranging from +4.0% to +30.7% at the 90-day mark. His cross-ticker track record across 8 prior buys shows an average 90-day return of +12.8% with a 90-day win rate of 100.00%, though this reflects activity across all tickers and should not be conflated with DTM-specific outcomes.

CFO Jeffrey Jewell buys 185 DTM shares at $136.33; prior 5 buys at ticker all show positive 90d returns (4.0%–30.7%).

Jewell, DT Midstream's Executive V.P. and CFO, purchased 185 shares at $136.33 on 2026-02-25 for $25,221.05, raising his holdings to 89,582 shares. His five prior open-market buys at DTM between May 2024 and August 2025 each delivered positive 90-day returns ranging from 4.0% to 30.7%, with 100% of those trades proving well-timed. The company's fundamentals remain solid: $314.0M latest-quarter revenue, $115.0M net income, and 26.7% annual revenue growth, though the stock trades at a P/E of 28.48 relative to a $14.0B market cap. Current price is $137.28, just 0.5% below the 52-week high, up 12.8% over 30 days and 15.0% over 90 days, indicating strong recent momentum.

CFO Jeffrey Jewell buys 150 DTM shares at $104.38; extends pattern of 4 prior well-timed buys at same ticker.

Jewell, the CFO, purchased 150 shares at $104.38 on 2025-08-07, a relatively small addition to his 64.4K-share position. His prior four measurable buys at DTM were all well-timed at the 90-day mark, with cumulative 90-day returns of +4.0%, +8.3%, +30.7%, and +19.2%, suggesting consistent pattern recognition of entry points. The stock is currently trading at $104.21—just below the transaction price—and lies -8.4% from its 52-week high of $113.75, placing it in the lower half of its annual range. Fundamentals show solid operational performance with $309.0M in latest quarterly revenue and net income of $107.0M against a P/E of 28.16; the company's +6.4% annual revenue growth and $10.6B market cap frame a mid-sized, profitable enterprise. The repeat buy pattern at this specific ticker warrants attention as a data point, though the small share increment ($15.7K) and modest current price movement (+1.4% over 30 days) require context.

CFO Jeffrey A Jewell buys 65 DTM shares at $100.15; prior trades at ticker show 2 of 2 measurable outcomes well-timed with +30.7% and +19.2% 90d returns.

Jewell (Executive V.P., CFO) purchased 65 shares at $100.15 on 2025-05-09, a modest transaction of $6.5K that increased his holdings to 64.2K shares. His same-ticker history shows a pattern of well-timed entry: his two prior DTM buys with measurable 90-day outcomes (2024-08-09 and 2024-05-03) returned +30.7% and +19.2%, respectively. The current stock price of $101.24 places the transaction near-at-cost (+1.1 bps), and the stock is -11.0% from its 52-week high but +8.8% over 30 days. While his cross-ticker track record shows 100% 90-day win rate, the present buy occurs in a relatively expensive valuation environment (P/E 28.20) and the company is reporting strong fundamentals: $303.0M revenue, $108.0M net income, and +6.4% annual growth. The modesty of the share count relative to his existing position and the small transaction size ($6.5K) suggest this reflects ongoing portfolio maintenance rather than a material new conviction signal.

Director Skaggs buys 1,012 shares at $86.37 blended average; prior DTM trade well-timed with 16.7% gain.

Robert C. Skaggs Jr. acquired 1,012 shares across 15 transactions from October 2021 through March 2025, with the bulk (1,000 shares at $86.92) concentrated in the most recent transaction on 2025-03-10. His prior purchase at DTM on 2024-02-26 posted a 90-day return of +16.7%, establishing a pattern of well-timed entry points at this ticker. The current price of $93.43 sits -8.0% over the 30-day window and -17.9% below the 52-week high of $113.75, placing the blended purchase price of $86.37 near recent lows but above the 52-week floor of $57.56. With net holdings now at 38.7K shares (a +2.7% increase), the director's incremental positioning occurs against a backdrop of modest revenue growth of +6.4% annually and a P/E ratio of 25.46, neither signal of distress nor exceptional opportunity. The consistent pattern of small scheduled purchases followed by a material discrete buy suggests opportunistic accumulation rather than systematic portfolio adjustment.

E.V.P. Ellis Wendy sells 18,854 shares at ~$93/share for $1.75M, reducing stake by 74.6%

Ellis Wendy, Executive Vice President, General Counsel & Corporate Secretary, executed two separate sales on 2025-03-04 totaling 18,854 shares for $1,753,804.12, reducing her holdings from 25,289 shares to 6,435 shares—a 74.6% reduction. The blended average price of $93.02 sits just 0.6% below the current price of $93.62, and within the 52-week range of $57.56–$113.75, where the stock has declined 17.7% from its high. At a P/E of 25.51 and market cap of $9.5B, DTM trades with elevated valuations, while the company's latest quarter showed $248.0M in revenue and $88.0M net income. The magnitude of the stake reduction and the executive's title suggest a material portfolio decision by a senior officer; however, no FLAGS indicating a scheduled trading plan are present, leaving the discretionary intent of the transaction open to investor scrutiny.

CFO Jeffrey A Jewell bought 170 DTM shares at $96.68; stock now $94.59, down 16.8% from 52-week high amid 90d decline of 8.0%.

Jewell's purchase of 170 shares at $96.68 represents a modest $16.4K addition to his 64.2K-share position, occurring as DTM trades 16.8% below its 52-week high and off 8.0% over the past 90 days. His cross-ticker track record shows 4 prior buys with a 100.00% 90-day win rate and an average 90-day return of 25.0%, while his same-ticker history at DTM demonstrates 2 of 2 measurable prior buy outcomes were well-timed at the 90-day mark (posting +30.7% and +19.2% returns respectively). However, this transaction arrives amid near-term price weakness: the stock is down 6.4% over the past 30 days, making near-term timing visibility limited. The company's fundamentals remain solid with $248.0M quarterly revenue, $88.0M net income, and 6.4% annual revenue growth, though the 25.77 P/E ratio is elevated for the current price action.

CFO Jeffrey A Jewell bought 200 DTM shares at $74.22; strong fundamentals ($96.0M net income, $244.0M revenue) support conviction.

CFO Jewell Jeffrey A purchased 200 shares at $74.22, bringing his holdings to 44,485 shares. The transaction occurs in a favorable price context: the stock is up 2.2% over 30 days and up 9.9% over 90 days, trading 4.0% below its 52-week high of $75.54. His prior DTM buys show a 2-of-3 pattern of positive 90-day outcomes, with the most recent purchase (2024-05-03) delivering +6.8% at 30 days and +19.2% at 90 days. The company's fundamentals are solid, with $244.0M in quarterly revenue and $96.0M in net income; however, annual revenue growth stands at +0.2%, indicating flat top-line expansion. The insider's cross-ticker track record shows a 66.67% win rate at 90 days with an average 90-day return of +8.2%, providing additional context for his buy discipline. This purchase reflects a modest accumulation, though the relatively small position increase (+0.5% vs prior holdings) suggests incremental rather than aggressive positioning.